Polymorphism in the beta subunit and Na+ transport

Journal of the American Society of Nephrology

Volumn 7, Issue 12, 1996, Pages 2490-2494

  Warnock, David G ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Amiloride; CAMP; Epithelial Na+ channel; Liddle's syndrome

Indexed keywords

CYCLIC AMP; PROTEIN SUBUNIT; SODIUM CHANNEL;

ARTICLE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIDDLE SYNDROME; PRIORITY JOURNAL; SODIUM TRANSPORT;

EID: 0030378049     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Lifton RP, Dluhy RG, Powers M, et al.: Hereditary hypertension caused by chimeric gene duplications and extopic expression of aldosterone synthase. Nat Genet 1992;2:66-74.
2. Shimkets RA, Warnock DG, Bositis CM, et al.: Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell. 1994;79:407-414.
3. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC: Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 1995;10:394-399.
4. Su YR, Rutkowski MP, Klanke CA, et al.: A novel variant of the β-subunit of the amiloride-sensitive sodium channel in African Americans. J Am Soc Nephrol 1996;7: 2543-2549.
5. + channels. Am J Physiol (Cell Physiol) 1991;260:C1071-C1084.
6. + channels by hormonal and autoregulatory mechanisms of action. J Gen Physiol 1991;98:1197-1220.
7. Canessa CM, Schild L, Buell G, et al.: The amiloride- sensitive epithelial sodium channel is made of three homologous subunits. Nature 1994;367:463-467.
8. Stutts MJ, Canessa CM, Olsen JC, et al.: CFTR as a cAMP-dependent regulator of sodium channels. Science 1995;269:847-850.
9. + channel. J Gen Physiol 1996;108:49-65.
10. Saxena S, Oh Y, Quick M and Warnock DG: cAMP regulation of wild type amiloride-sensitive sodium channels expressed in Xenopus oocytes. J Am Soc Nephrol 1996;7:1289A.
11. + channels. J Memb Biol 1995;143:1-19.
12. Bubien JK, Jope RS, Warnock DG: G-proteins modulate amiloride-sensitive sodium channels. J Biol Chem 1994; 269:17780-17783.
13. + channels by β-subunit mutation. Am J Physiol (Cell Physiol) 1996;270:C208-C213.
14. Botero-Velez M, Curtis JJ, Warnock DG: Brief report: Liddle's syndrome revisited. N Engl J Med 1994;330: 178-181.
15. Liddle GW, Bledsoe T, Coppage WS: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Am Assoc Physicians 1963;76:199-213.
16. Bubien JK, Warnock DG: Amiloride sensitive sodium conductance in human B lymphoid cells. Am J Physiol (Cell Physiol) 1993;265:C1175-C1183.
17. Bradford AL, Ismailov II, Achard J-M, Warnock DG, Bubien JK, Benos DJ: Immunopurification and functional reconstitution of an amiloride-sensitive Na channel protein from rat lymphocytes. Am J Physiol (Cell Physiol) 1995;269:C601-C611.
18. Oh Y, Warnock DG: Expression of the amiloride- sensitive sodum channel β subunit gene in human B lymphocytes. J Am Soc Nephrol 1997, in press.
19. Schild L, Canessa CM, Shimkets RA, Gautschi I, Lifton RP, Rossier BC: A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA 1995;92:5699-5703.
20. + channel. Cell 1995;83:969-978.
21. Tamura H, Schild L, Enomoto N, Matsui N, Marumo F, Rossier BC, Susaki S: Liddle disease caused by a missense mutation of β subunit of the epithelial sodium channel gene. J Clin Invest 1996;97:1780-1784.
22. Hansson JH, Schild L, Lu Y, et al.: A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci USA 1995;92:11495-11499.
23. Hansson JH, Nelson-Williams C, Suzuki H, et al.: Hypertension caused by a truncated epithelial sodium channel γ subunit: Genetic heterogeneity of Liddle syndrome. Nat Genet 1995;11:76-82.
24. + channels in Liddle's disease. Am J Physiol (Cell Physiol) 1996;270:C214-C223.
25. + channel (αrENaC) mediates its localization at the apical membrane. EMBO J 1994;13:4440-4450.
26. +)- ATPase. Am J Physiol (Renal Fluid Electrolyte Physiol) 1995;269:F637-F643.
27. + channel regulation. Kidney Int 1995;48:970-984.
28. Achard J-M, Bubien JK, Benos DJ, Warnock DG: Stretch modulates amiloride sensitivity and cation selectivity of sodium channels in human B lymphocytes. Am J Physiol (Cell Physiol) 1996;270:C224-C234.
29. Huang K, Chalfie M: Gene interactions affecting mechanosensory transduction in Caenorhabditis elegans. Nature 1994;367:467-470.
30. Tripodi G, Valtorta F, Torielli L, et al.: Hypertension- associated point mutations in the Adducin a and b subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996;97:2815-2822.
31. + transport. J Clin Invest 1996;97:2691.
32. Warnock DG, Bubien JK: Liddle's syndrome: A public health menace? Am J Kidney Dis 1995;25:924-927.
33. Reinhard M, Giehl K, Abel K, Haffner C, Jockusch BM, Walter U: The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J 1995;14:1583-1589.
34. Chen L, Williams SK, Schafer JA: Differences in synergistic actions of vasopressin and deoxycorticosterone in rat and rabbit CCD. Am J Physiol (Renal Fluid Electrolyte Physiol) 1990;259:F147-F156.
35. Griffing GT, Wilson TE, Melby JC: Alterations in aldosterone secretion and metabolism in low renin hypertension. J Clin Endocrinol Metab 1990;71:1454-1460.
36. Thom TJ, Kannel WB: Downward trend in cardiovascular mortality. Annu Rev Med 1981;32:427-434.
37. The 1984 report of the Joint Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1984;144:1045-1057.
38. Qualheim R, Rostand SG, Kirk KA, Rutsky EA, Luke RG: Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis 1991;23:336-343.
39. Brazy PC, Fitzwilliam JT: Progressive renal disease: Role of race and antihypertensive medication. Kidney Int 1990;37:1113-1119.
40. U.S. Renal Data System: USRDS 1989 Annual Report. Bethesda, MD: National Institutes of Health; 1990:A1- A11.
41. Whittle JC, Whelton PK, Seidler AJ, Klag MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Int Med 1991;151:1359-1364.
42. Weller JM, Wu S-C, Ferguson W, Hawthorne VM: End- stage renal disease in Michigan: Incidence, underlying causes, prevalence and modalities of treatment. Am J Nephrol 1985;5:84-95.
43. Rostand SG, Kirk KA, Rutsky EA, Pate BA: Racial differences in the incidence of treatment for end-stage renal disease. New Engl J Med 1982;306:1276-1279.
44. McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 1988;12: 285-290.
45. Verdecchia P, Schillaci G, Guerreri M, et al.: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-536.
46. Ferguson R, Grim CE, Opgenorth AJ: A familial risk of chronic renal failure among blacks on dialysis. J Clin Epidemiol 1988;41:1189-1196.
47. Freedman BI, Spray BJ, Tuttle AB, Buckalews VMJ: The familial risk of end-stage renal disease in African- Americans. Am J Kidney Dis 1993;21:387-393.
48. Curtis JJ, Luke RG, Dustan HP, et al.: Remission of essential hypertension after renal transplantation. N Engl J Med 1983;309:1009-1015.
49. Curtis JJ, Luke RG, Diethelm AG, Welchel JD, Jones P: Benefits of removal of native kidneys in hypertension after renal transplantation. Lancet 1985;2:739-742.
50. Frohlich ED, Messerli FZ, Dunn FG, Oigman W, Ventura HO, Sundgaard-Riise K: Greater renal vascular involvement in the black patient with essential hypertension: A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab 1984; 10:173-177.
51. Levy SB, Talner LB, Coel MN, Holle R, Stone RA: Renal vasculature in essential hypertension: Racial differences. Ann Intern Med 1978;88:12-16.
52. Tracy RE, Mercante DE, Moncada A, Berenson G: Quantitation of hypertensive nephrosclerosis on an objective rational scale of measure in adults and children. Am J Clin Pathol 1985;85:312-318.
53. Hollenberg NK, Borucki LJ, Adams DF: The renal vasculature in early essential hypertension: Evidence for a pathogenetic role. Medicine 1978;57:167-178.
54. Van Hooft IMS, Grobbee DE, Derkx FHM, deLeeuw PW, Schalekamp MADH, Hoffman A: Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991;324:1305-1311.
55. Luft FC, Miller JZ, Cohen SJ, Fineberg NS, Weinberger MH: Heritable aspects of salt sensitivity. Am J Cardiol 1988;61:1-6.
56. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986;8: 127-134.
57. Cooper RS, Borke JL. Intracellular ions and hypertension in blacks. In: Fray JCS, Douglas J, Fray JCS, Douglas JS, Eds. Pathophysiology of Hypertension in Blacks. New York: Oxford; 1993:181-213.
58. Cooper R, Rotimi C: Hypertension in populations of West African origin: Is there a genetic predisposition? J Hypertension 1994;12:215-227.
59. Warren SE, O'Connor DT: Does a renal vasodilator system mediate racial differences in essential hypertension? Am J Med 1980;69:425-429.
60. Falkner B: Differences in blacks and whites with essential hypertension: Biochemistry and endocrine. Hypertension 1990;15:681-686.
61. Fisher ND, Gleason RE, Moore TJ, Williams GH, Hollenberg NK: Regulation of aldosterone secretion in hypertensive blacks. Hypertension 1994;23:179-184.
62. + channel. Am J Physiol 1994; 266:L728-L734.